Pharmaceutical Industry News
Analysis of regulation, quality, innovation, market and trends in Europe and Latin America.
Anvisa – 25th anniversary of the Generics Policy
The generic drugs policy, established in 1999, represented an important step forward for the country's public health....
Reports assess risk and benefit of drug list
ANVISA has announced the availability of the list of medicines that must submit Periodic Benefit-Risk Assessment Reports....
Anvisa approves new Covid-19 vaccine
The covid-19 (recombinant) immunizing zika vaccine with s-protein and saponin-based adjuvant has been approved....
Anvisa publishes new edition of the Biosurveillance Manual
The document provides guidelines on monitoring adverse events in transplants, grafts and assisted human reproduction....
Brazil to be present at 15 global food fairs in 2023
MAPA aims to boost national agribusiness, taking advantage of opportunities to promote Brazilian products on the market....
Anvisa approves new treatment for advanced cancer in Brazil
Anvisa has approved a gene therapy drug to treat hematologic cancer (gene therapy using patients' genetically modified T cells)....
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Rely on experts to support your regulatory decisions and accelerate the growth of your products safely and efficiently.
Strategic consulting for the pharmaceutical, healthcare, food, and medtech industries.
Experts in pharmaceutical consulting, regulatory strategy, and market access to support your company with safety, compliance, and efficiency. Talk to a consultant.